Dennis Mulroy serves as Executive at LA JOLLA PHARMACEUTICAL CO, where they oversee executive responsibilities. Since joining the company, Dennis Mulroy has executed 58 insider transactions totaling $2.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 15, 2019 involved receiving (via award) 316 shares valued at $1.8K.
Dennis Mulroy currently holds 21,852 shares of LA JOLLA PHARMACEUTICAL CO (LJPC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dennis Mulroy has been a net seller of LJPC stock. They have purchased $17.0K and sold $2.2M worth of shares.
Dennis Mulroy's most recent insider trade was on Jan 15, 2019, when they sold 316 shares at $5.74 per share.
Get notified when new Form 4 filings are submitted
| $8.02 |
| Discretionary |
| Dec 14, 2018 | LJPC | $305 | Award | 28 | $10.88 | Discretionary |
| Nov 30, 2018 | LJPC | $320 | Award | 26 | $12.30 | Discretionary |
| Nov 15, 2018 | LJPC | $304 | Award | 24 | $12.67 | Discretionary |
| Oct 31, 2018 | LJPC | $305 | Award | 22 | $13.86 | Discretionary |
| Oct 15, 2018 | LJPC | $304 | Award | 22 | $13.81 | Discretionary |
| Mar 3, 2017 | LJPC | $17.0K | Purchase | 500 | $33.95 | Discretionary |